Ann Custin
Follow
Get notifications in MyBN when activity occurs.
Ann Custin
Non-Executive Director / Volpara Health Technologies
Ann Custin has almost 40 years of experience in the healthcare sector across the US, Europe and Asia. She also has experience in strategy, financial planning and reporting, portfolio management, sales operations, manufacturing, risk management, business and corporate development.
Ms Custin was a board director and chief financial officer of medical technology company Siemens Medical Solutions (now Siemens Healthineers), chief operating and financial officer of Scient'x Group, and the president & chief executive of USA Draeger Medical Systems.
She is a director of two women's health-focused companies, ASX-listed Volpara Health and NASDAQ-listed Establishment Labs, and non-executive director of Mayne Pharma Group.
Ms Custin was a board director and chief financial officer of medical technology company Siemens Medical Solutions (now Siemens Healthineers), chief operating and financial officer of Scient'x Group, and the president & chief executive of USA Draeger Medical Systems.
She is a director of two women's health-focused companies, ASX-listed Volpara Health and NASDAQ-listed Establishment Labs, and non-executive director of Mayne Pharma Group.
Lists and Charts
Total Shareholder Return as at 30/09/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 335th | Mayne Pharma Group | 41% | -15% |
1743 WA (and selected non WA) listed companies ranked by
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Roles
Year started and most recent title
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| th |  | Mayne Pharma Group | $390.1m |
1333 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Person Activity
| NEW ROLE: Non-Executive Director, Volpara Health Technologies | 29 Mar 2022 |
| NEW ROLE: Non-Executive Director, Mayne Pharma Group | 29 Mar 2022 |
